Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

Todd Neale

September 17, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Conference News HRS 2019

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

Todd Neale

May 10, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

Advertisement

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

September 2024 Dispatch for the CV Team

August 2024 Dispatch for the CV Team

Kidney Events High in Older Patients After HF Hospitalization

BP Reduction With Renal Denervation Still Evident a Decade On

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Registry Data Hint at MACE Benefit With Renal Denervation

January 2022 News Roundup

December 2021 News Roundup

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Renal Denervation a Third Option for Hypertension, European Experts Say

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content